Track the evolution of major financial and economic events
Fastenal faces pressure ahead of its Q2 2026 earnings report on July 13, amid analyst concerns over valuation and margin headwinds. Analysts project a 12.7% increase in EPS to $0.33 and a 12.5% rise in revenue to $2.34 billion. While some firms maintained a neutral stance due to overvaluation risks, the company saw a 14.8% boost in daily sales during May driven by strong manufacturing and construction demand. Price targets for the stock currently range between $46 and $55.
UBS raised its price target for Fifth Third Bancorp from $60 to $65 while maintaining a Buy rating. This follows reports that the bank significantly increased its holdings in major companies like Walmart and Mastercard during the first quarter. Specifically, the bank's stake in Walmart rose by 55.2% to $462.6 million, while its ownership in Mastercard grew by 25.7% to a total value of $435.5 million.
BofA Securities raised its price target for IBM to $330, fueled by optimism over Confluent software revenue growth ahead of the Q2 earnings report on July 22, 2026. The company released preliminary financial results on July 14, entering the earnings period with strong momentum in AI and cloud sectors. Despite this growth, IBM faces pressure from a premium valuation and investor concerns regarding profit margins.
Hodges Capital Management increased its stake in Philip Morris by 575.9% during the first quarter, following the company's strong Q1 results which included $1.96 earnings per share and $10.15 billion in revenue. Additionally, Fifth Third Bancorp raised its holdings in Philip Morris by 70.3%, acquiring an additional 401,858 shares. During the same period, the institution also grew its stake in Amgen by 57.2%, bringing its total investment value in the company to $162.3 million.
Bristol Myers Squibb's Krazati, in combination with cetuximab, failed to significantly improve survival rates in metastatic colorectal cancer patients compared to chemotherapy. Meanwhile, the European Medicines Agency has initiated a rolling review of Revolution Medicines' experimental treatment for pancreatic cancer. Additionally, HitGen announced that its partner BioAge Labs has commenced a Phase 2 clinical trial for BGE-102, an oral inhibitor targeting cardiovascular risk.
Microbot Medical reported over 100% growth in revenue and new customers for Q2 2026, announcing plans to expand its U.S. sales territories and enter international markets. The period also saw significant M&A activity, with BiomX signing a letter of intent to acquire an Israeli security infrastructure firm, and Stereotaxis completing its acquisition of robotic innovator Robocath. Additionally, IKS Health finalized its acquisition of TruBridge, a provider of EHR and revenue cycle management solutions.
CACI International received a contract ceiling increase exceeding $140.5 million from the U.S. Army on July 7. This was followed by the award of a six-year contract valued at up to $308 million from the U.S. Department of Veterans Affairs on July 8. Additionally, on July 13, the company secured a U.S. Department of Defense contract to deploy its SkyValor drone defense technology along the Southern Border.
Last week saw significant financial activity, starting on July 7 when CCHH entered the Malaysian data center market with a $50 million maintenance services agreement. On the same day, CDT Environmental Technology regained compliance with Nasdaq's minimum bid price requirement. Subsequently, on July 10, HCC Healthcare signed a business combination agreement with RF Acquisition Corp III to pursue a listing on the Nasdaq stock exchange.
Goldman Sachs is scheduled to report its Q2 earnings results on July 14, 2026. Analysts expect significant growth, projecting a 32.60% increase in earnings per share to $14.47. Quarterly revenues are forecasted to reach $16.49 billion, representing a 13.10% year-over-year increase from the previous year.
On July 7, Kailera Therapeutics announced that its GLP-1 drug for diabetes and obesity met the primary endpoints in two late-stage trials. On the same day, the U.S. Food and Drug Administration approved Vera Therapeutics' drug to treat a potentially life-threatening kidney disease. On July 9, Dr. Reddy's Laboratories announced a delay in commercial supplies of semaglutide due to an issue with the active pharmaceutical ingredient.
Global semiconductor stocks experienced a selloff that pressured Nasdaq 100 futures, leading traders to monitor the 50-day moving average support. Despite a brief recovery in chip stocks on July 10, the NASDAQ Composite fell 0.90% by July 13, slipping below its 200-hour moving average. Concurrently, the S&P 500 remained below key resistance levels while holding near its 200-hour moving average support.
Cintas is set to report its fiscal Q4 earnings on July 15, with analysts expecting $1.23 EPS and $2.87B in revenue. The company recently faced a regulatory delay in its merger with UniFirst following a request from the FTC. As the earnings release approaches, investor attention is focused on revenue growth, customer retention, and the operational impact of recent acquisitions.
Global semiconductor stocks declined following a selloff in Samsung shares triggered by its quarterly earnings report on July 7. On July 14, the European Commission approved €659 million in German state aid to support four first-of-a-kind semiconductor facilities. These events highlight market volatility alongside strategic initiatives to bolster manufacturing capabilities in Europe.
Wall Street sentiment is increasingly turning positive toward SpaceX ahead of its anticipated inclusion in the Nasdaq 100 index. On July 8, famed investor Jeremy Grantham described SpaceX's inclusion in the Nasdaq 100 as the 'craziest IPO in the history of man'.
West Red Lake Gold reported high-grade drill results at the Madsen Mine, featuring 43.38 g/t Au over 3.85m, while Osisko Development announced extended gold mineralization at the Cariboo Project beyond 700m depth. In the digital asset sector, Bitfufu produced 125 BTC in June, showing a decrease in daily average production compared to May. Additionally, the company's total power capacity under management dropped to 273 MW from the previous month's 346 MW.
Deutsche Bank initiated coverage on Porvair with a Buy rating, citing expectations for sustained earnings growth. Meanwhile, Black Rock Coffee Bar reported revenue growth to $200.3M in 2025, targeting 1,000 locations by 2035 with a projected 20% annual growth rate. Additionally, pension fund Railpen submitted a revised takeover offer for IP Group, though Deutsche Bank suggests the board may require further concessions before recommending the proposal.
Unifor, the Canadian autoworkers union, entered critical negotiations with Ford to secure a new three-year contract, setting a Friday deadline for a deal. Representing 5,150 members, the union sought improvements in wages, job security, and pensions, eventually extending talks beyond the initial deadline. Ultimately, Ford and Unifor reached a tentative labor agreement, successfully averting a potential strike.
Shell expects its gas-trading division to report significantly higher Q2 results compared to the first quarter of 2026, offsetting production declines caused by lost Qatari volumes. Additionally, the company completed the $1.8 billion sale of India’s Sprng Energy to Aditya Birla Renewables. These updates reflect a surge in trading performance despite lower output in the integrated gas unit.
M&T Bank is scheduled to release its Q2 earnings report on July 15, 2026, with analysts forecasting earnings of $4.67 per share. Indicators suggest the bank is likely to beat estimates, driven by anticipated growth in loans and higher net interest income. While analysts expect overall growth, elevated costs remain a primary concern that could impact profitability margins. The positive outlook for M&T Bank reflects a broader trend of expected growth across several financial institutions reporting next week.
Bleichroeder Acquisition Corp. III announced the pricing of its $300 million IPO, offering 30 million units at $10 each on the Nasdaq Global Market under the ticker BCCQU. Additionally, Mercator Acquisition Corp. raised $172.5 million through its own Nasdaq IPO. Meanwhile, Tavia Acquisition Corp. and Vita Inclinata Technologies signed a Letter of Intent for a business combination, which would result in Vita becoming a publicly traded company on Nasdaq through a de-SPAC process.
L3Harris Technologies secured a series of major contracts, starting with a $499.6 million award from the U.S. Missile Defense Agency. The company also received $84 million in orders from the U.S. Army for Next Generation Command and Control Falcon systems, marking its second award under that program. Furthermore, L3Harris landed an FAA contract to modernize and operate the national aircraft tracking network through 2045, involving upgrades to over 700 ground stations.
Black Rock Coffee Bar is facing a securities class action lawsuit regarding misleading disclosures in its September 2025 IPO documents. The lawsuit centers on the company's alleged failure to properly disclose the adverse impact of a 'sales transfer phenomenon' to investors. During the initial public offering, the company issued approximately 16.9 million shares at a price of $20 per share.
Postal Realty Trust expanded its unsecured credit facilities to $615 million, achieving a 30 basis point improvement in pricing. In other corporate developments, Principal Industries acquired GENLED Brands, and Whitestone REIT shareholders approved an all-cash acquisition by Ares Real Estate funds. Additionally, GameStop shareholders authorized a share count increase to fund the proposed acquisition of eBay.
TechnipFMC secured a major subsea contract from Eni for the Baleine Phase 3 project offshore Côte d'Ivoire, involving the design and manufacture of flexible flowlines and risers at depths of 1,200 meters. Additionally, the company was awarded multiple subsea tie-back contracts by Equinor in Norway. Meanwhile, EU antitrust regulators are launching a full-scale investigation into the merger between Saipem and Subsea 7 due to competition concerns within the subsea services sector.
